Nikon 2013 Annual Report Download - page 20

Download and view the complete annual report

Please find page 20 of the 2013 Nikon annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 68

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68

REVIEW OF OPERATIONS
In bioscience, Nikon is taking advantage of live
cell imaging and other leading-edge technologies
to pioneer new fields and expand its business
operations. We will also acquire a leading
position in the industrial instruments field with
differentiated products for both non-contact
metrology and X-ray inspection systems.
Review of the Fiscal Year Ended March 2013
Net sales declined slightly in the fiscal year ended
March 2013, while the operating loss increased as
a result of the rising value of the yen during the
first half of the period, and a market downturn in
the second half resulted in curbs being placed on
capital expenditures, as well as continued shrinking
public spending and project delays.
Throughout the entire fiscal year we faced
unprecedented difficulties, as a result of the
simultaneous deterioration of the bioscience and
industrial instruments markets. Despite that,
however, we were able to increase our market
share in both areas, because of earlier investment
aimed at business expansion. The next-generation
products that contributed to the increased market
share include bioscience-related high-end system
products, and industrial instruments-related non-
contact 3D measuring instruments.
EXPANDING
THE NETWORK
Highlights of the Fiscal Year Ended March 2013
• Net sales ¥53,877 million (down 3.8% year on year)
• Operating loss of ¥4,978 million (operating loss of
¥3,166 million in the previous fiscal year)
• Bioscience—increase in market share amid shrinking
public spending
• Industrial instruments—increase in sales of non-
contact 3D measurement systems amid cutbacks in
capital expenditures
18
INSTRUMENTS
COMPANY
TOSHIYUKI MASAI
Director, Member of the Board and
Executive Officer
President of Instruments Company